Search by Drug Name or NDC

    NDC 17478-0544-30 Adenosine 3 mg/mL Details

    Adenosine 3 mg/mL

    Adenosine is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Akorn. The primary component is ADENOSINE.

    Product Information

    NDC 17478-0544
    Product ID 17478-544_7d38776e-0cb1-491f-8033-506267830415
    Associated GPIs 94200005002010
    GCN Sequence Number 031430
    GCN Sequence Number Description adenosine VIAL 3 MG/ML INTRAVEN
    HIC3 A6V
    HIC3 Description CARDIOVASCULAR DIAGNOSTICS,NON-RADIOPAQUE AGENTS
    GCN 35352
    HICL Sequence Number 003734
    HICL Sequence Number Description ADENOSINE
    Brand/Generic Generic
    Proprietary Name Adenosine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Adenosine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 3
    Active Ingredient Units mg/mL
    Substance Name ADENOSINE
    Labeler Name Akorn
    Pharmaceutical Class Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090450
    Listing Certified Through 2024-12-31

    Package

    NDC 17478-0544-30 (17478054430)

    NDC Package Code 17478-544-30
    Billing NDC 17478054430
    Package 1 VIAL in 1 CARTON (17478-544-30) / 30 mL in 1 VIAL
    Marketing Start Date 2014-10-02
    NDC Exclude Flag N
    Pricing Information N/A